| 000 | 01850 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513160246.0 | ||
| 264 | 0 | _c19990325 | |
| 008 | 199903s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1038/sj.bjp.0702215 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReuben, M | |
| 245 | 0 | 0 |
_aPersistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cNov 1998 |
||
| 300 |
_a1218-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlkaloids _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAzocines |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChlorisondamine _xpharmacokinetics |
| 650 | 0 | 4 |
_aDizocilpine Maleate _xpharmacology |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agonists _xpharmacology |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aN-Methylaspartate _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNicotinic Antagonists _xpharmacokinetics |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 | _aPC12 Cells |
| 650 | 0 | 4 | _aQuinolizines |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 |
_aSynaptosomes _xdrug effects |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aLouis, M | |
| 700 | 1 | _aClarke, P B | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 125 _gno. 6 _gp. 1218-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0702215 _zAvailable from publisher's website |
| 999 |
_c9826425 _d9826425 |
||